Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Beckman Coulter

This article was originally published in The Gray Sheet

Executive Summary

Beckman Coulter: Proceeds of a planned $400 mil. private placement of senior notes will be used to prepay a portion of its existing bank borrowings - incurred to fund the combination of Beckman Instruments and Coulter Corporation in October 1997 - and finance a tender offer to repurchase its $100 mil. in 7.05% debentures due June 1, 2026. The offering, which is anticipated to close on March 4, consists of $160 mil. in senior notes due March 4, 2003, with an annual interest rate of 7.1% and $240 mil. in senior notes due March 4, 2008, with an annual interest rate of 7.45%...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT009644

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel